{"id":1156,"date":"2026-05-28T01:50:14","date_gmt":"2026-05-28T01:50:14","guid":{"rendered":"https:\/\/littleheroesfoundation.org\/?p=1156"},"modified":"2026-05-28T01:50:14","modified_gmt":"2026-05-28T01:50:14","slug":"immunohistochemical-ihc-assays-of-specimen-from-internal-and-external-validation-cohort-supplementary-physique-s1andsupplementary-table-s1-showed-ack1-expression-was-highly-located-in-the","status":"publish","type":"post","link":"https:\/\/littleheroesfoundation.org\/?p=1156","title":{"rendered":"\ufeffImmunohistochemical (IHC) assays of specimen from internal and external validation cohort (Supplementary Physique S1andSupplementary Table S1) showed Ack1 expression was highly located in the cytoplasm (Figure1Ca), and further validated that the expression level of Ack1 was significantly higher in HCC tumors than that in ANLTs (Figure1Cb&1Cc)"},"content":{"rendered":"

\ufeffImmunohistochemical (IHC) assays of specimen from internal and external validation cohort (Supplementary Physique S1andSupplementary Table S1) showed Ack1 expression was highly located in the cytoplasm (Figure1Ca), and further validated that the expression level of Ack1 was significantly higher in HCC tumors than that in ANLTs (Figure1Cb&1Cc). of HCC is still far from satisfactory due to large sulfaisodimidine incidences of tumor recurrence and metastasis, [2, 3] with a 5-year recurrence price of approximately 60% after hepatic resection in our and sulfaisodimidine<\/a> other centers. [2, 4, 5] Therefore , It is important to further study the molecular mechanisms underlying metastasis of HCC and to study novel prognostic biomarkers intended for HCC. We have previously recognized a specific subtype of hepatocellular carcinoma, solitary large hepatocellular carcinoma (SLHCC, only one nodule, and tumor diameter > 5 cm), with a reduce rate of tumor recurrence and metastasis and a better long-term survival outcome, compared with nodular hepatocellular carcinoma (NHCC, tumor nodules 2). [4] Further clinical studies verified that the metastatic potential of SLHCC was comparable with small hepatocellular carcinoma (SHCC, 5 cm in diameter), but significantly lower than NHCC. [2, 4] To understand the molecular mechanisms underlying the difference of metastatic potential between SLHCC and NHCC, cDNA microarray analysis was used to identify difference of gene profile between both of these subtypes of HCC. [6, 7] Among the 8464 human being genes screened, 313 genes were up-regulated in NHCC than in SLHCC, including RhoC, [810] protocadherin LKC [6, 7] and Ack1. Ack1, a nonreceptor tyrosine kinase, was originally identified as a Cdc42-interacting protein and a Cdc42 effector. [11, 12] Ack1 overexpression has been observed in multiple human being cancers including prostate, gastric, and pancreatic cancers. [1315] Substantial data indicate that Ack1 is implicated in metastatic behavior, cell spreading and migration. [16] Overexpression of Ack1 can increase the invasive phenotype of breast cancer cells [17] and mediate melanoma cell spreading. [18] These data indicate that Ack1 is involved in invasion and metastasis in HCC, yet its precise role in HCC remains unclear. Metastasis of tumors leads to a very poor prognosis intended for patients suffering from cancer. [3] We postulate Ack1 may be a poor prognostic biomarker and is associated with Rabbit Polyclonal to CSRL1<\/a> HCC metastasis. In the present study, we determined Ack1 expression as well as clinical significance of prognostic marker in HCC in accordance to REMARK guidelines intended for reporting prognostic biomarkers in cancer. [19] We further identified the effect of Ack1 on metastasis of HCC and its underlying molecular mechanism by using a series ofin vitroandin vivoassays. == RESULTS == == Ack1 expression is significantly increased in HCC tissues == Previous cDNA microarray analysis was performed to identify difference of gene sulfaisodimidine profile between SLHCC and NHCC. [6, 7] Results showed that Ack1 expression was significantly higher in HCC tissues than in surrounding nontumorous liver tissues (ANLTs). Furthermore, Ack1 expression was also significantly higher in NHCC than in SLHCC. To confirm the results of cDNA microarray, quantitative real time-PCR (qRT-PCR) was performed sulfaisodimidine to determine Ack1 expression in 76 HCCs of training cohort (Supplementary Figure S1andSupplementary Table S1). Ack1 mRNA was up-regulated in HCC tumors compared with that in ANLTs (0. 0347 0. 0187vs. 0. 0049 0. 0064, P < 0. 0001, Figure1A). Semiquantitative RT-PCR and western blot (Figure1B) showed the similar results because qRT-PCR in these matched specimens. Immunohistochemical (IHC) assays of specimen from internal and external validation cohort (Supplementary Figure S1andSupplementary Table S1) showed Ack1 expression was highly located in the cytoplasm (Figure1Ca), and further validated the expression degree of Ack1 was significantly higher in HCC tumors than that in ANLTs (Figure1Cb&1Cc). Taken with each other, these data proved the expression of Ack1 was up-regulated in HCC. == Figure 1 . Ack1 expression is significantly increased in HCC and correlated with HCC metastasis. == A. Ack1 mRNA of tumor tissues in the training cohort is higher than that in ANLTs by quantitative real-time PCR (qRT-PCR)..\n<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffImmunohistochemical (IHC) assays of specimen from internal and external validation cohort (Supplementary Physique S1andSupplementary Table S1) showed Ack1 expression was highly located in the cytoplasm (Figure1Ca), and further validated that the expression level of Ack1 was significantly higher … <\/p>\n

Continue reading “\ufeffImmunohistochemical (IHC) assays of specimen from internal and external validation cohort (Supplementary Physique S1andSupplementary Table S1) showed Ack1 expression was highly located in the cytoplasm (Figure1Ca), and further validated that the expression level of Ack1 was significantly higher in HCC tumors than that in ANLTs (Figure1Cb&1Cc)”<\/span><\/a><\/div>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-1156","post","type-post","status-publish","format-standard","hentry","category-sec7"],"_links":{"self":[{"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/1156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1156"}],"version-history":[{"count":1,"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/1156\/revisions"}],"predecessor-version":[{"id":1157,"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/1156\/revisions\/1157"}],"wp:attachment":[{"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/littleheroesfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}